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arget genes of the protooncogene c-
 
myc
 
 are impli-
cated in cell cycle and growth control, yet the link-
age of both is still unexplored. Here, we show that
the products of the nucleolar target genes Pes1 and Bop1
form a stable complex with a novel member, WDR12 (Pe-
BoW complex). Endogenous WDR12, a WD40 repeat
protein, is crucial for processing of the 32S precursor ri-
bosomal RNA (rRNA) and cell proliferation. Further, a
conditionally expressed dominant-negative mutant of
T
 
WDR12 also blocks rRNA processing and induces a re-
versible cell cycle arrest. Mutant WDR12 triggers accumu-
lation of p53 in a p19ARF-independent manner in prolif-
erating cells but not in quiescent cells. Interestingly, a
potential homologous complex of Pes1–Bop1–WDR12 in
yeast (Nop7p–Erb1p–Ytm1p) is involved in the control of
ribosome biogenesis and S phase entry. In conclusion, the
integrity of the PeBoW complex is required for ribosome
biogenesis and cell proliferation in mammalian cells.
 
Introduction
 
Coordination of cell growth and cell division is a fundamental
prerequisite for proliferating cells to remain constant in size
(Polymenis and Schmidt, 1999; Fingar et al., 2002; Schmidt,
2004). Ribosome biogenesis, the major constituent of cellular
growth, accounts for up to 80% of the energy consumption of
dividing cells (Thomas, 2000). Disturbances in the ribosome
synthesis pathway must be detected and coupled with cell cycle
progression to prevent premature cell divisions. The fact that
the oncogenic transcription factor c-Myc efficiently promotes
proliferation might result from its capacity to positively regu-
late both ribosome biogenesis and cell cycle progression
(Schmidt, 1999, 2004). Yet it remains unclear how c-Myc
achieves this concerted action.
The 
 
c-myc
 
 protooncogene is implicated in proliferation,
cell growth, differentiation, and apoptosis (Oster et al., 2002;
Nilsson and Cleveland, 2003; Pelengaris and Khan, 2003;
Schmidt, 2004). Deregulated expression is associated with a
variety of human neoplasias. Several high throughput tech-
niques have substantially extended the list of potential c-Myc
target genes (Fernandez et al., 2003; Li et al., 2003; Patel et al.,
2004). Transcriptional control by c-Myc has been reported on
hundreds of genes (Coller et al., 2000; Guo et al., 2000; Schuh-
macher et al., 2001). One major subset of target genes is in-
volved in ribosome biogenesis and cell metabolism. Other gene
products exert cell cycle control. Indeed, c-Myc is of pivotal
importance to promote entry into and to prevent exit from the
cell cycle (Eilers et al., 1991; Hölzel et al., 2001; Trumpp et al.,
2001). On the other hand, constitutive expression of c-Myc me-
diates accumulation of cell mass (Schuhmacher et al., 1999;
Kim et al., 2000). These findings suggest that c-Myc target
genes physiologically act in concert to promote proliferation
while ensuring the equilibrium between cell growth and cell
cycle progression. However, the mechanisms that survey bal-
anced cell divisions in mammalian cells remain largely unex-
plored. Nevertheless, several recent studies have considerably
enlarged our knowledge. Intriguing links between nucleolar
function and cell cycle control have emerged.
Conditional deletion of the ribosomal protein gene S6 in
mice impeded cell cycle entry of liver cells after partial hepa-
tectomy (Volarevic et al., 2000). Surprisingly, hepatocytes of
starved mice regained their baseline cell size after feeding de-
spite the lack of ribosomal protein S6. Thus, ribosome biogene-
sis is essential for proliferation but not for accumulation of cell
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mass. Several mechanisms have been proposed that couple nu-
cleolar function to cell cycle control. Interestingly, they all im-
ply the tumor suppressor p53.
First, the Mdm2 oncoprotein mediates the proteasomal
degradation of p53 (Stommel et al., 1999; Tao and Levine,
1999a; Boyd et al., 2000). The p19ARF tumor suppressor dis-
rupts Mdm2–p53 binding, sequesters the former to the nucleo-
lus, and thus stabilizes p53 (Tao and Levine, 1999b; Weber et
al., 1999). Another mechanism proposes nuclear export of p53
via the nucleolus for subsequent degradation in the cytoplasm
(Sherr and Weber, 2000). In fact, Mdm2–p53 complexes are
found in conjunction with the ribosomal proteins L5 and L11
(Marechal et al., 1994; Lohrum et al., 2003; Zhang et al., 2003).
These findings suggest that Mdm2–p53 complexes assemble
with ribosomes for their CRM1-dependent nuclear export. In-
deed, it was shown that a subset of ribosomes contained cyto-
plasmic p53 covalently linked to 5.8S ribosomal RNA (rRNA;
Fontoura et al., 1992, 1997). Hence, the nucleolar export model
directly couples nucleoplasmic p53 levels to the functional state
of ribosome biogenesis. This model received substantial support
as it was demonstrated that DNA damage by localized UV irra-
diation of cell nuclei failed to trigger stabilization of the tumor
suppressor p53 unless the nucleolus was affected (Rubbi and
Milner, 2003). Moreover, the literature confirms that all p53-
inducing stresses cause nucleolar disruption besides the ones
that act downstream of the nucleolus such as the proteasome and
nuclear export inhibitors MG132 and leptomycin B, respec-
tively (Rubbi and Milner, 2003). Recently, it was shown that the
ribosomal proteins L5, L11, and L23 negatively regulate Mdm2
activity (Lohrum et al., 2003; Zhang et al., 2003; Dai and Lu,
2004; Jin et al., 2004). Proliferating cells incorporate L5, L11,
and L23 into functional ribosomes. Disturbances in the ribo-
some synthesis pathway, in contrast, result in the accumulation
of free ribosomal proteins. The subsequent inhibition of Mdm2
by L5, L11, and L23 causes activation of p53.
Hence, the nucleolus is a common stress sensor of pivotal
importance in the p53 response. Therefore, precise knowledge
about ribosome biogenesis is required to unravel the signals
that transmit nucleolar disturbance to the cell cycle. Several ge-
netic and proteomic studies in yeast provided intriguing details
of the complex molecular machinery needed for ribosome syn-
thesis (Fatica and Tollervey, 2002; Fromont-Racine et al.,
2003; Saveanu et al., 2003; Takahashi et al., 2003). As an ex-
ample, yeast Nop7p (Yph1p) has been implicated in the control
of ribosome biogenesis and DNA replication via its interaction
with origin recognition complex proteins (Du and Stillman,
2002). Two other proteins, Erb1p and Ytm1p, have been copu-
rified with Nop7p in a small core complex. Remarkably, Bop1,
the human homologue of Erb1p, plays a role in rRNA process-
ing and cell cycle control (Strezoska et al., 2002). Dominant-
negative mutants of Bop1 interfered with proper rRNA pro-
cessing and provoked a p53-dependent cell cycle arrest (Pestov
et al., 2001). More recently, Bop1 was shown to interact with
Pes1, the mammalian homologue of Nop7p (Lapik et al.,
2004). This indicates that a set of evolutionarily conserved pro-
teins might coordinate ribosome biogenesis with DNA replica-
tion in mammalian cells.
Previously, we identified a considerably large number of
c-Myc target genes involved in rRNA processing (Schlosser et
al., 2003). It received our particular attention that c-Myc up-
regulated the expression of 
 
pes1
 
, 
 
bop1
 
, and 
 
wdr12
 
. Mammalian
WD repeat protein 12 (WDR12) is the putative homologue of
yeast Ytm1p. It is tempting to speculate that in analogy to
yeast, Pes1, Bop1, and WDR12 might function in an evolution-
arily conserved complex. Thus, c-Myc dependent up-regula-
tion of these three factors might promote the formation of a
subcomplex that is important for the assembly of larger preri-
bosomal complexes and the cross talk between ribosome bio-
genesis and proliferation control.
However, the biological functions of mammalian WDR12
are yet unknown. WDR12 mRNA is ubiquitously expressed
during embryogenesis and high levels are found in the thymus
and testis of adult mice. In addition, GST pull-down experi-
ments revealed an interaction with Notch1-IC, therefore sug-
Figure 1. c-Myc controls endogenous wdr12  expression. (A) Northern
blot analysis of wdr12 expression in the human B cell line P493-6 carrying
a tetracycline-controllable c-myc gene. Removal of tetracycline from the cul-
ture medium by several washes with PBS strongly stimulated exogenous
c-myc expression. As a control, separate cultures were treated equally,
however, in the presence of tetracycline. Equal amounts of total RNA were
hybridized with radioactively labeled probes specific for human c-myc,
wdr12, bop1, and pes1. Expression of gapdh was not affected by c-Myc.
Bottom panel shows ethidium bromide staining as loading control. P, prolif-
erating cells; A, arrested cells. (B) Northern blot analysis of WDR12 expres-
sion in TGR-1 rat fibroblasts. TGR-1 cells were stably transfected with a con-
struct encoding a doxycycline-inducible human c-myc gene. Cells were
arrested by contact inhibition to reduce endogenous c-myc levels. Addition
of doxycycline to the culture medium strongly activated exogenous c-myc
expression. Equal amounts of total RNA were hybridized with radioactively
labeled probes specific for human c-myc and rodent wdr12, bop1, and
pes1. Expression of gapdh was not affected by c-Myc. Bottom panel shows
ethidium bromide staining as loading control. (C) Western blot analysis of
WDR12 expression in P493-6 cells. Cells were treated as described in A.
Immunodetection was performed with antibodies against c-Myc (N-262),
WDR12 (1B8), Bop1, Pes1, and  -tubulin (DM1A). 
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gesting a role in early stages of primary T cell differentiation
(Nal et al., 2002). The high homology between mammalian
WDR12 and yeast Ytm1p prompted us to study the role of
WDR12 in ribosome biogenesis and cell proliferation.
 
Results
 
c-Myc up-regulates WDR12
 
First, we analyzed the expression of WDR12 in a human B cell
line (P493-6) harboring a 
 
c-myc
 
 tet-off system (Schuhmacher
et al., 1999). Proliferation of P493-6 cells is 
 
c-myc
 
 dependent.
After the induction of 
 
c-myc
 
, 
 
wdr12
 
 mRNA was similarly up-
regulated as 
 
bop1
 
 and 
 
pes1
 
 (Fig. 1 A). To rule out cell line–
specific observations, we established TGR-1 rat fibroblasts
carrying a 
 
c-myc
 
 tet-on system. Addition of doxycycline to the
culture medium induced rapid and strong 
 
c-myc
 
 expression re-
sulting likewise in up-regulation of endogenous 
 
wdr12
 
, 
 
bop1
 
,
and 
 
pes1
 
 mRNA levels (Fig. 1 B). Further, we raised mono-
clonal antibodies specific against human WDR12, Bop1, and
Pes1. Proliferating P493-6 cells expressed high levels of all
three proteins in contrast to arrested cells (Fig. 1 C). Consis-
tently, endogenous WDR12, Bop1, and Pes1 accumulated sub-
sequent to conditional c-Myc expression.
 
WDR12 is a nuclear protein with 
predominant nucleolar localization
 
To determine the cellular localization of endogenous WDR12,
we performed indirect immunofluorescence. WDR12 localized
to the nucleolus and nucleoplasm in various cell lines such as
U2OS (Fig. 2 A, top), HeLa, and WI-38 (not depicted). Further,
human diploid fibroblasts were cotransfected with expression
constructs coding for WDR12-eYFP and eCFP-nucleophosmin
fusion proteins. WDR12-eYFP exhibited diffuse nucleoplasmic
distribution, strong accumulation within the nucleolus, and nu-
cleolar colocalization with nucleophosmin (Fig. 2 A, bottom).
Similar results were obtained in rodent fibroblasts (unpublished
data). Interestingly, nucleolar localization was also reported for
GFP- and HA-tagged forms of yeast Ytm1p, the potential homo-
logue of mammalian WDR12 (Ouspenski et al., 1999; Huh et al.,
2003). Hence, our data provide for the first time experimental
evidence that mammalian WDR12 and yeast Ytm1p are poten-
tial homologues exhibiting similar subcellular distribution.
Figure 2. Subcellular localization and mu-
tagenesis of WDR12. (A) Endogenous WDR12
was visualized by indirect immunofluores-
cence in PFA-fixed U2OS cells (top). Nuclei
were counterstained with DAPI. Human dip-
loid fibroblasts were transiently cotransfected
with constructs encoding the WDR12-eYFP
and eCFP-Nucleophosmin fusion proteins. A
representative image of a transfected cell is
shown (bottom). (B) Outline of domain-specific
mutagenesis of WDR12. Several truncation
mutants of HA-tagged human WDR12 were
generated and cloned into pRTS plasmids al-
lowing doxycycline-dependent gene expres-
sion. (C) Western blot analysis of wild-type
and mutant WDR12-HA in stably transfected
TGR-1 fibroblasts. The indicated polyclonal
cell lines were treated with doxycycline for 24 h
( ) or left untreated ( ). Bottom panel shows
Ponceau S staining as loading control. (D)
Analysis of subcellular localization of WDR12
mutants. TGR-1 cells were stably transfected
with the indicated constructs and treated with
doxycycline for 24 h. Methanol-fixed cells
were analyzed by indirect immunofluores-
cence. Representative images are shown in
each panel. Nuclei are visualized by DAPI
staining. As control, cells expressing lu-
ciferase were equally analyzed (Mock). Bars:
(A) 10  m; (D) 20  m. 
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Mutational analysis of WDR12
 
Next, we aimed to assess the biological functions of WDR12
by mutational analysis. WDR12 belongs to the family of WD
repeat proteins that are generally thought to regulate protein–
protein interactions (Smith et al., 1999). These factors con-
sist of several copies of a defined amino acid motif, the WD
domain. WDR12 contains seven COOH-terminal WD re-
peats, as predicted by BMERC analysis (Nal et al., 2002).
Crystallographic studies of other factors with seven WD re-
peats revealed that the WD domains form a “propeller-like”
structure composed of seven “blades” (Wall et al., 1995).
The NH
 
2
 
 terminus of WDR12 has significant similarity to the
NH
 
2
 
-terminal part of Notchless, a protein implicated in the
modulation of Notch signaling in 
 
Drosophila melanogaster
 
(Royet et al., 1998; Nal et al., 2002). This defined structural
organization of WDR12 prompted us to generate a panel of
different truncation mutants (Fig. 2 B). We established stable
polyclonal cell lines of TGR-1 rat fibroblasts that express
WDR12 wild-type or mutant forms together with eGFP from
a bidirectional promoter in a doxycycline-dependent manner
(unpublished data). After doxycycline treatment, 
 
 
 
95% of
the cells were eGFP positive, as monitored by flow cytome-
try in each experiment. Levels of HA-tagged WDR12 mu-
tants were determined by immunoblotting (Fig. 2 C). Some
mutant forms of WDR12-HA were detected at the calculated
molecular size, whereas others exhibited multiple products at
a significantly lower size (Fig. 2 C, lanes 3, 5, and 6). This is
most likely due to rapid degradation of unstable mutant
forms. Interestingly, all unstable WDR12 mutants lack the
first three WD domains.
Further, we examined the cellular localization of WDR12
mutants by immunofluorescence (Fig. 2 D). As expected, the
HA-tagged wild-type form of WDR12 localized to the nu-
cleolus. Surprisingly, only WDR12 lacking the NH
 
2
 
-terminal
Notchless-like domain (WDR12
 
 
 
Nle) also exhibited predomi-
nant nucleolar staining. The remaining WDR12 mutants dis-
persed in the cytoplasm and nucleoplasm.
 
WDR12
 
 
 
Nle inhibits proliferation
 
To test whether wild-type WDR12 or mutants affect prolifera-
tion, we seeded equal numbers of stable TGR-1 cell cultures at
low density in the presence of doxycycline. After 6 d, the num-
ber of cells was determined in multiples and compared with the
mean cell count of a mock cell line expressing luciferase (Fig.
3 A). Enforced expression of exogenous wild-type WDR12
neither impaired nor promoted cell proliferation. However, de-
letion of the NH
 
2
 
-terminal Notchless-like domain resulted in a
strongly reduced cell count. We excluded an increase of apop-
tosis by Annexin V staining using flow cytometry as a potential
explanation for this observation (unpublished data). Hence, the
block of proliferation in response to enforced WDR12
 
 
 
Nle ex-
pression is due to cell cycle arrest rather than increased cell
death. To support this hypothesis, we performed BrdU light as-
says (Pestov and Lau, 1994). Thereby we investigated whether
enforced WDR12
 
 
 
Nle expression elicits a reversible cell cycle
arrest. In brief, dividing cells that incorporate BrdU into their
DNA become highly photosensitive if they are additionally la-
beled with Hoechst dye and irradiated with light. Hence, cell
cycle–arrested cells are protected from increased photosensitiv-
ity and survive BrdU light treatment. Conditional WDR12
 
 
 
Nle
expression efficiently rescued TGR-1 cells from BrdU light
treatment, whereas wild-type WDR12 failed to do so (Fig. 2 B).
As controls, we generated stable cell lines expressing wild-type
Bop1, Bop1
 
 
 
 and Bop1N2, two previously described domi-
nant-negative mutants of Bop1 (Pestov et al., 2001; Strezoska
et al., 2002).
To further examine the impact of WDR12
 
 
 
Nle expres-
sion on cell proliferation, we performed cell cycle analysis us-
ing flow cytometry (Fig. S1, available at http://www.jcb.
org/cgi/content/full/jcb.200501141/DC1). Overexpression of
Bop1
 
 
 
, as previously shown, led to accumulation of cells in
G1 and reduction in S phase (Pestov et al., 2001). Albeit the
strong inhibitory effect of WDR12
 
 
 
Nle on cell proliferation,
we observed only slight alterations of the cell cycle distri-
bution and a less pronounced accumulation in G1 than in
Bop1
 
 
 
-expressing cells. Hence, our data suggests that in ad-
dition to a complete G1 arrest, cells may also exhibit delayed
overall cell cycle progression in response to WDR12
 
 
 
Nle and
probably also Bop1
 
 
 
.
Figure 3. WDR12 Nle inhibits cell proliferation and elicits a reversible
cell cycle arrest. (A) Equal numbers of TGR-1 cells stably transfected with
the indicated constructs were seeded in multiples in the presence of doxy-
cycline. After 6 d, cells were trypsinized and counted by trypan blue ex-
clusion. Final cell counts of the indicated cell lines were compared with a
mock cell line that expresses luciferase. Histograms depict the relative cell
counts after 6 d. Error bars indicate SD. (B) Reversible cell cycle arrest by
WDR12 Nle overexpression. Stably transfected TGR-1 cells were seeded
at low density and treated with doxycycline for 30 h to induce expression
of the specified constructs. Subsequently, cells were incubated with 100  M
BrdU for 48 h to label proliferating cells. Visible light irradiation in the
presence of 2  M Hoechst 33258 selectively kills cells that have incorpo-
rated BrdU into their DNA. Arrested cells survive BrdU light treatment and
give rise to cell colonies after withdrawal of doxycycline. Images show
representative BrdU light assays conducted with the indicated cell lines. 
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Mutants lacking the first three WD40 repeats in addition
to the deleted Notchless-like domain failed to block prolifera-
tion. Thus, disrupted integrity of the WD repeat domains rescued
the inhibitory effect of WDR12
 
 
 
Nle. Noteworthily, these mu-
tants also exhibited aberrant subcellular distribution. Our data
suggest that the dominant-negative phenotype of WDR12
 
 
 
Nle
depends on its nucleolar localization.
 
WDR12
 
 
 
Nle interferes with rRNA 
processing
 
From the aforementioned results we reasoned that
WDR12
 
 
 
Nle might confer its inhibitory effect on cell prolif-
eration via interference with rRNA processing. Besides, there
is accumulating evidence in the literature supporting our no-
tion. Yeast Ytm1p, the potential homologue of WDR12, in-
teracts with Erb1p and Nop7p (Yph1p) in a complex that
links ribosome biogenesis with DNA replication (Du and
Stillman, 2002). Bop1 and Pes1, the candidate mammalian
homologues of Erb1p and Nop7p, both play a role in rRNA
processing and, moreover, also physically interact (Strezoska
et al., 2002; Lapik et al., 2004). Therefore, we investigated
the levels of different rRNA species in WDR12
 
 
 
Nle-express-
ing TGR-1 and U2OS cells by Northern blot analysis (Fig. 4,
A and B). Total RNA was probed with sequences specific for
the ITS1 and ITS2 (internal transcribed spacer) of rRNA in-
termediates (Fig. 4 A). WDR12
 
 
 
Nle-expressing cells accu-
mulated the 32S rRNA precursor (Fig. 4 B). In another set of
experiments, we studied the impact of WDR12
 
 
 
Nle on rRNA
processing in TGR-1 cells by metabolic 
 
32
 
P in vivo labeling
(Fig. 4 C). The production of mature 28S rRNA was severely
reduced resulting from an inefficient processing of the 32S
rRNA precursor, as concluded from the decreased ratio of
28S/18S rRNA (Fig. 4 D). Synthesis of mature 18S rRNA
was almost unaffected, as determined by the signal intensity
of the 18S rRNA normalized to the total RNA loading. These
results are in line with our Northern blot analysis. In conclu-
sion, WDR12
 
 
 
Nle primarily compromises ribosome biogen-
esis by blocking processing of the 32S rRNA precursor into
mature 28S rRNA.
 
Endogenous WDR12 is required for 
rRNA processing and cell proliferation
 
To confirm the role of WDR12 in ribosome biogenesis and cell
proliferation, we performed small interfering RNA (siRNA)
knockdown experiments of endogenous WDR12. U2OS cell
were transfected at day 0, 1, and 2 with either control or
WDR12-specific siRNA. Expression of endogenous WDR12
was dramatically reduced, as monitored by Western blot analy-
sis 2 d after the last transfection (Fig. 5 A). Moreover, prolifer-
ation of WDR12-depleted cells was severely impaired (Fig. 5 B).
Further, we investigated the impact of WDR12 knockdown on
ribosome biogenesis. Levels of precursor and mature rRNA
species were determined by Northern blot analysis 2 d after the
last siRNA transfection. WDR12-depleted cells exhibited ac-
cumulation of the 32S precursor rRNA and a concomitant re-
duction of the mature 28S rRNA (Fig. 5 C). To study more
immediate effects of WDR12 knockdown on rRNA process-
Figure 4. WDR12 Nle expression affects rRNA processing. (A) Diagram
of the primary 47S rRNA transcript and the major rRNA intermediates.
Positions of the hybridization probes are depicted. ETS, external tran-
scribed spacer; ITS, internal transcribed spacer. (B) Northern blot analysis
of rRNA precursors in WDR12 Nle-expressing TGR-1 and U2OS cells.
Indicated cell lines were treated with doxycycline for 30 h. Equal amounts
of total RNA were hybridized with probes specific for the ITS1 and ITS2 of
rRNA intermediates. As loading control, blots were incubated with a
probe specific for 18S rRNA. (C) WDR12 Nle expression impairs forma-
tion of mature 28S rRNA. Asynchronously growing TGR-1 cells were
treated with or without doxycycline for 24 h. Cells were pulse labeled with
32P-orthophosphate for 45 min and chased in regular medium as indi-
cated. (D) Ratio of 28S/18S rRNA at 120 min after metabolic labeling
with 
32P-orthophosphate as described in C. 
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ing, cells were transfected only twice at day 0 and 1 and in vivo
labeling of rRNA was performed 2 d later. Again, the produc-
tion of the mature 28S rRNA was drastically compromised
(Fig. 5 D). Notably, synthesis of the large 45/47S precursor
was not affected, indicating that WDR12 is not involved in
rRNA transcription. In conclusion, expression of dominant-
negative WDR12
 
 
 
Nle and depletion of endogenous WDR12
block rRNA processing of the 32S rRNA precursor and restrain
cell proliferation.
 
WDR12
 
 
 
Nle triggers accumulation of p53
 
Disruption of the nucleolus is a common feature of a variety
of stresses such as DNA damage. It has been previously pos-
tulated that impairment of nucleolar function is the “common
denominator” to mediate stabilization of p53 (Rubbi and Mil-
ner, 2003). Based on these findings, we explored the p53 re-
sponse after enforced WDR12
 
 
 
Nle expression in asynchro-
nously proliferating TGR-1 cells (Fig. 6 A, top). Indeed,
WDR12
 
 
 
Nle in contrast to wild-type WDR12 mediated an
accumulation of endogenous p53. The dominant-negative
mutants Bop1
 
 
 
 and Bop1N2 also stabilized p53. Thus, accu-
mulation of p53 apparently is a common feature of compro-
mised rRNA processing. Next, we investigated the conditions
under which WDR12
 
 
 
Nle mediates stabilization of p53. To-
tal cell lysates of proliferating and arrested cells were ana-
lyzed by immunoblotting. Interestingly, p53 failed to accu-
mulate in serum-starved cells (Fig. 6 A). Similarly, contact
inhibition resulted in an alleviated p53 response. Equal ex-
pression of exogenous proteins was verified by immunoblot-
ting (unpublished data). Likewise, we studied the endogenous
p53 response by immunofluorescence and examined the per-
centage of p53-positive cells (Fig. 6 B). In proliferating TGR-
1 fibroblasts, WDR12 Nle provoked an accumulation of p53
in almost 60% of the cells (Fig. 6 C). Intensity and percentage
of p53-positive nuclei diminished in the case of contact inhi-
bition and serum starvation. Consistent results were obtained
for Bop1  and Bop1N2. In summary, p53 accumulation in re-
sponse to inhibition of rRNA processing is especially pro-
nounced in proliferating cells compared with quiescent cells.
We also tested whether the accumulation of p53 was associ-
ated with phosphorylation at serine 15. Interestingly, we ob-
served an increase of serine 15–phosphorylated p53 congru-
ently with the overall accumulation of p53 (Fig. S2, available
at http://www.jcb.org/cgi/content/full/jcb.200501141/DC1).
Further, we investigated the WDR12 Nle-mediated p53 re-
sponse by analyzing the transcriptional activation of the p53-
responsive gene p21 using quantitative real-time PCR (Fig. 6
D). Induction of p21 mRNA resembled the accumulation of
p53 in response to WDR12 Nle expression (Fig. 6 A, top;
and Fig. 6 D).
As previously demonstrated, Bop1  and Bop1N2 elicited
a p53-dependent cell cycle arrest that was attenuated by the co-
expression of the human papillomavirus protein E6, a ubiquitin
ligase targeting p53 for degradation (Scheffner et al., 1993). In
line with these studies, WDR12 Nle-induced cell cycle arrest
was alleviated in TGR-1 cells stably transfected with HA-
tagged E6 (Fig. 6 E). Interestingly, overexpression of wild-type
Bop1 was accompanied with increased p53 levels. This corre-
sponds to the weak but significant rescue of wild-type Bop1 in
the BrdU light assay (Fig. 3 B).
Accumulation of p53 is independent of 
the tumor suppressor p19ARF
To explore the mechanism of p53 accumulation mediated by
interference with rRNA processing, we studied the role of
p19ARF in this response. The tumor suppressor p19ARF se-
questers Mdm2 to the nucleolus and triggers stabilization of
p53 (Sherr and Weber, 2000). In unstressed cells, nucleoplas-
mic Mdm2 targets p53 for degradation via ubiquitination.
Overexpression of p19ARF inhibits rRNA processing in a
p53-independent manner and binds to 5.8S rRNA. Therefore,
p19ARF might be required for the accumulation of p53 in
response to WDR12 Nle. Stable polyclonal cell lines of
p19ARF /  and p53 /  MEFs were generated that condi-
tionally express wild-type WDR12, WDR12 Nle, and Bop1 .
Upon exogenous gene activation, endogenous p53 levels were
visualized by immunoblotting (Fig. 6 F). Indeed, overexpres-
sion of WDR12 Nle and Bop1  provoked accumulation of
p53 in p19ARF /  cells. Hence, the tumor suppressor
p19ARF is dispensable for an appropriate p53 response elicited
by inhibition of rRNA processing.
Figure 5. Endogenous WDR12 is required for rRNA processing and cell
proliferation. (A) U2OS cells were transfected at day 0, 1, and 2 with ei-
ther control or WDR12-specific siRNA. Endogenous WDR12 levels were
analyzed by Western blot analysis 2 d after the last transfection.  -Tubulin
is shown as a loading control. (B) U2OS cells were seeded in multiples at
low density and treated as described in A. Cells were counted at days 0,
4, and 7. Error bars indicate SD. (C) U2OS cells were treated as in A and
total RNA was harvested 2 d after the last transfection. Different rRNA spe-
cies were visualized by Northern blot analysis using probes specific for
human ITS-1, ITS-2, 28S, and 18S rRNA. (D) U2OS cells were transfected
only twice at day 0 and 1 and metabolically labeled with 
32P-orthophos-
phate for 60 min at day 3. Subsequently, cells were incubated for 3 h in
regular culture medium.MAMMALIAN WDR12 IS A NOVEL MEMBER OF THE PES1–BOP1 COMPLEX • HÖLZEL ET AL. 373
WDR12 forms a stable complex with 
Bop1 and Pes1
Because the potential yeast homologues Nop7p (Yph1p),
Erb1p, and Ytm1p form a stable core complex (Harnpicharn-
chai et al., 2001; Du and Stillman, 2002), we finally asked
whether endogenous Pes1, Bop1, and WDR12 also constitute a
stable complex in mammalian cells. Monoclonal antibodies
were raised against all three proteins and applied in immuno-
precipitation experiments. Each protein was specifically immu-
noprecipitated and also coimmunoprecipitated the two other
proteins (Fig. 7 A). Even though our results strongly suggested
that the proteins participate in common complexes, the number
and abundance of endogenous complexes containing Pes1,
Bop1, and WDR12 remained unknown. Therefore, we per-
formed native gel electrophoresis using stringent cell lysis condi-
tions to unravel stable core complexes. Strikingly, immunoblot
analysis of all three proteins exhibited a single major band at
the same height of the native gel, indicating the existence of
one stable complex. Overexpression of the respective exoge-
nous components of the complex resulted in faster migrating
bands indicating free nonincorporated proteins (unpublished
data). Moreover, the presence of each protein in this complex
was verified by subsequent second dimension gel electrophore-
sis under denaturing conditions followed by immunoblotting.
Figure 6. WDR12 Nle provokes accumulation of the tumor suppressor
p53. (A) Western blot analysis of endogenous p53 levels. TGR-1 cells
were stably transfected with the indicated constructs. Asynchronously pro-
liferating, serum starved (72 h), and contact inhibited cells were treated
with doxycycline for 24 h to induce expression of the respective products.
Equal amounts of whole cell lysates were analyzed by immunoblotting
using anti-p53 (Pab122) antibodies. The top band corresponds to a non-
specific signal, as verified in p53 /  cells (F). The nonspecific band in-
dicates equal loading in addition to Ponceau S staining (not depicted).
Identical expression of the HA-tagged constructs was visualized by immu-
noblotting with anti-HA (3F10) antibody (not depicted). (B) Percentage of
p53-positive nuclei in TGR-1 cells upon induction of the dominant-negative
mutants WDR12 Nle, Bop1 , and Bop1N2. Asynchronously proliferat-
ing (p), serum-starved (s), and confluent (c) cells were analyzed by im-
munofluorescence as described in C. Numbers of examined cells are
indicated at the bottom. Error bars indicate SD of the percentage of p53-
positive nuclei cells per high power field. (C) Analysis of the endogenous
p53 response to WDR12 Nle expression by indirect immunofluores-
cence. Asynchronously proliferating, serum-starved (72 h), and contact-
inhibited cells were treated with doxycycline for 24 h to induce
WDR12 Nle. Cells were fixed in methanol and stained with anti-p53
(Pab122). Cell nuclei were counterstained with DAPI. Representative im-
ages are shown. Bar, 60  m. (D) Asynchronously proliferating TGR-1 cells
stably transfected with the indicated constructs were treated with doxycy-
cline for 24 h. Levels of p21 mRNA were analyzed by quantitative real-
time PCR. Fold induction was normalized to the expression of aldolase.
(E) WDR12 Nle-mediated reversible cell cycle arrest is alleviated by func-
tional impairment of the endogenous p53 response in TGR-1 cells stably
transfected with the HA-tagged human papillomavirus protein E6. Identi-
cal numbers of TGR-1 and TGR1-HA-E6 cells both conditionally expressing
WDR12DNle were subjected to BrdU light treatment as described. Images
show representative methanol-fixed and GIEMSA-stained cell cultures.
(F) Accumulation of p53 is independent of p19ARF. p19ARF /  and
p53 /  MEFs were stably transfected with the indicated constructs.
Asynchronously proliferating cells were treated with doxycycline for 24 h
and equal amounts of whole cell lysates were analyzed by immunoblot-
ting with anti-p53 antibody.
Figure 7. Endogenous WDR12 forms a stable complex with endogenous
Pes1 and Bop1. (A) Asynchronously proliferating U2OS cells were har-
vested and immunoprecipitations were performed using antibodies
against WDR12, Pes1, Bop1, and Cytohesin, as an IgG1 isotype control.
Subsequently, immunoblotting was performed using antibodies against
Pes1, Bop1, and WDR12, respectively. *, non specific band; **, IgG
heavy chain. (B) Total cell lysates of U2OS cells were separated by native
gel electrophoresis. Endogenous Bop1, Pes1, WDR12, and  -tubulin were
visualized by immunoblotting. Arrows indicate complexes containing the
respective factor. In another set of experiments, native gel electrophoresis
was followed by a second denaturing gel electrophoresis. Afterwards,
Bop1, Pes1, and WDR12 were detected by immunoblotting using the re-
spective antibodies as mix or alone. Anti-Pes1 usually generates a very
strong signal compared with the weaker signal of the anti-WDR12 anti-
body. (right) Arrows indicate Bop1, Pes1, and WDR12, respectively.JCB • VOLUME 170 • NUMBER 3 • 2005 374
Hence, endogenous Pes1, Bop1, and WDR12, like their poten-
tial yeast homologues, form a stable core complex in mamma-
lian cells (PeBoW complex).
Discussion
Using cDNA microarrays, we previously identified numerous
c-Myc target genes involved in ribosome biogenesis and dem-
onstrated a global role for c-Myc in the control of efficient
rRNA processing (Schlosser et al., 2003). Pes1, Bop1, and
WDR12 are the products of three target genes that received our
particular attention. Pes1 and Bop1 are directly interacting pro-
teins involved in rRNA processing and proliferation (Strezoska
et al., 2002; Lapik et al., 2004). In addition, the respective yeast
homologues Nop7p (Yph1p) and Erb1p have been copurified
in preribosomal complexes (Harnpicharnchai et al., 2001; Du
and Stillman, 2002; Saveanu et al., 2003). Moreover, Nop7p
and Erb1p assemble in a small subcomplex together with
Ytm1p (Harnpicharnchai et al., 2001; Du and Stillman, 2002).
Intriguingly, WDR12 is the most likely homologue of Ytm1p
in mammalian cells. Proteomic and genetic studies suggest a
role for Ytm1p in the maturation of the 60S ribosomal subunit
and chromosomal stability (Ouspenski et al., 1999; Harnpi-
charnchai et al., 2001). Mammalian WDR12 has been cited as a
Notch1-IC interacting protein; however, its biological func-
tions remain unexplored (Nal et al., 2002).
In this study, we demonstrate that WDR12 is a crucial fac-
tor in the mammalian ribosome biogenesis pathway that forms a
stable complex with Pes1 and Bop1. We were able to show that
deletion of the evolutionarily conserved Notchless-like domain
of WDR12 results in a dominant-negative phenotype. Interfer-
ing with WDR12 function inhibits rRNA processing at specific
stages and blocks cell proliferation. Furthermore, we provide
evidence that accumulation of the tumor suppressor p53 is a
common phenomenon of impaired rRNA processing in a prolif-
eration-dependent manner.
WDR12 and ribosome biogenesis
A genome-wide GFP-tagging approach in yeast revealed nu-
clear and nucleolar localization of Ytm1p (Huh et al., 2003).
We demonstrated that endogenous WDR12, WDR12-HA, and
WDR12-eYFP fusion proteins were uniformly distributed in the
nucleoplasm and accumulated within the nucleolus. The similar
localization of Ytm1p and WDR12 supports the notion that both
proteins are indeed homologous proteins. Our subcellular local-
ization experiments using a monoclonal antibody that detects
endogenous WDR12 protein appear more reliable than overex-
pression studies that have reported a more homogeneous nuclear
distribution of eGFP-WDR12 in HeLa cells (Nal et al., 2002).
To determine whether WDR12 is a nucleolar factor re-
quired for ribosome biogenesis, we developed a series of trun-
cation mutants based on sequence-predicted domains. We
aimed to identify dominant-negative phenotypes by screening
for proliferation defects. Our results show that the NH2-termi-
nal Notchless-like domain is not required for nucleolar local-
ization of WDR12. In contrast, disrupting the integrity of the
seven WD repeats and therefore the potential propeller-like
structure caused aberrant nucleoplasmic and cytoplasmic distri-
bution. Among mutants that were tested, only WDR12 Nle
suppressed cell proliferation and inhibited proper rRNA pro-
cessing. Prominent accumulation of the 32S prerRNA indicates
defective processing in ITS2. Therefore, the NH2-terminal
Notchless-like domain probably mediates pivotal interactions
in preribosomal complexes, as its removal severely impairs
prerRNA processing. Importantly, our siRNA knockdown ex-
periments confirmed that endogenous WDR12 is required for
processing of the 32S precursor rRNA without affecting the
synthesis of the 45S/47S primary transcript. Collectively, these
results demonstrate that mammalian WDR12 functions in the
maturation of the 60S ribosomal subunit.
Inhibition of prerRNA processing and cell 
cycle control
Overexpression of WDR12 Nle strongly restrained cell prolifer-
ation without significant increase in apoptosis. Conducting BrdU
light assays, we demonstrated that WDR12 Nle imposes a re-
versible cell cycle arrest on TGR-1 rat fibroblasts. Similar results
have been reported on dominant-negative mutants of Bop1 and
Pes1, respectively (Pestov et al., 2001; Lapik et al., 2004). Like-
wise, depletion of endogenous WDR12 severely inhibited cell
proliferation. Thus, inhibition of prerRNA processing is coupled
with repression of cell proliferation. Noteworthily, changes in
cell cycle distributions were less pronounced as expected from
the proliferation and BrdU light assays. Hence, our data suggest
that in addition to a complete cell cycle arrest, the overall cell cy-
cle progression may also be delayed. The precise nature of this
interesting observation needs further investigation.
In a hallmark study, Pestov et al. (2001) demonstrated a
link between the tumor suppressor p53 and the response to “nu-
cleolar stress.” Impairment of endogenous p53 by the human
papillomavirus protein E6 abrogated the Bop1 -mediated cell
cycle arrest. Congruently, WDR12 Nle-triggered cell cycle ar-
rest was alleviated by the coexpression of HA-E6. Further, dom-
inant-negative mutants of WDR12 and Bop1 provoked consider-
able accumulation of nuclear p53 and transcriptional activation
of the target gene p21. Our results are in line with the study of
Rubbi and Milner (2003), supporting the model that compro-
mised functionality of the nucleolus is the basic principle of p53
stabilization in response to diverse stresses. Several intriguing
molecular mechanisms have been unravelled that might con-
tribute concertedly or independently to the overall increase in
nuclear p53. First, Mdm2–p53 complexes assembled with ribo-
somes argue for a nucleolar transit of p53 for subsequent cyto-
plasmic degradation. On the other hand, the ribosomal proteins
L5, L11, and L23 exert negative regulation on Mdm2 if they are
not incorporated into functional preribosomal complexes (Loh-
rum et al., 2003; Zhang et al., 2003; Dai and Lu, 2004; Jin et
al., 2004). Inhibition of prerRNA processing might result in an
oversupply of free L5, L11, and L23 and may thus facilitate sta-
bilization of p53 by blocking Mdm2 function. Our observations
are consistent with either model, because insufficient rRNA pro-
cessing reduces the production and export of mature ribosomes
in the same way as the demand for the ribosomal proteins L5,
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that the impact of WDR12 Nle or Bop1  expression on p53 ac-
cumulation should be dependent on the rate of ribosome biosyn-
thesis. Quiescent TGR-1 cells virtually shut down ribosome bio-
genesis (unpublished data). Hence, WDR12 Nle and Bop1  are
not expected to additionally increase nuclear p53 levels in ar-
rested cells. Indeed, we were able to demonstrate that dominant-
negative mutants of WDR12 and Bop1 failed to elicit p53 accu-
mulation in serum-starved cells. TGR-1 fibroblasts grown to
confluency gradually cease from the active cell division cycle.
Again, the p53 response provoked by WDR12 Nle, Bop1 , and
Bop1N2 expression was significantly diminished in confluent
compared with subconfluent cell cultures. Hence, inhibition of
rRNA processing by dominant-negative mutants is a p53-induc-
ing stress that depends on active ribosome biosynthesis. Interest-
ingly, we also found a congruent increase of p53 phosphorylated
at serine 15. Further investigation is needed to determine
whether it reflects concomitant baseline phosphorylation of ac-
cumulated p53 or a specific signaling cascade mediated by dis-
turbed rRNA processing. A recent study showed that human
WI-38 fibroblasts accumulated p53 under growth-restricting
conditions such as serum starvation and confluency (Bhat et al.,
2004). Evidently, TGR-1 rat fibroblasts differ in this aspect from
WI-38 cells. The precise explanation remains unclear. TGR-1
cells, however, are immortalized rodent cells that must have ac-
quired genetic aberrations to overcome senescence and therefore
might behave differently when challenged by unfavorable
growth conditions. Despite this obvious discrepancy, we con-
clude that WDR12 Nle, Bop1 , and Bop1N2 have no or little
effect on the baseline p53 levels under growth-restricting condi-
tions. Conclusively, proliferating cells require functional integ-
rity of the nucleolus to prevent accumulation of p53.
The tumor suppressor p19ARF regulates stability of p53
via sequestration of Mdm2 to the nucleolus (Sherr and Weber,
2000). In addition, overexpression of p19ARF impairs rRNA
processing (Sugimoto et al., 2003). Thus, p19ARF is a reason-
able candidate to meditate the p53 response triggered by
WDR12 Nle and Bop1 . Our results, however, demonstrate
that p19ARF is not required for accumulation of p53 provoked
by dominant-negative mutants of ribosome synthesis factors.
Finally, we demonstrated that endogenous Pes1, Bop1,
and WDR12 interact with each other in coimmunoprecipitation
assays. Moreover, native gel electrophoresis revealed that all
three proteins constitute only one major complex (PeBoW
complex). In yeast, several studies showed that the potential
homologous proteins Nop7p (Yph1p), Erb1p, and Ytm1p form
a stable trimeric core complex (Harnpicharnchai et al., 2001;
Du and Stillman, 2002). Potentially, the mammalian PeBoW
complex may also exist as a trimeric core complex; however,
we still cannot rule out that other factors may participate in the
PeBoW complex. Most likely, the PeBoW complex is a stable
subcomponent of larger preribosomal particles. Thus, previous
studies in yeast and our data suggest that this core complex is
evolutionarily conserved and its integrity is crucial for ribo-
some biogenesis and cell proliferation. It will be of outstanding
interest to unravel whether the mammalian PeBoW complex
directly plays a role in processes other than ribosome biogenesis,
such as cell cycle control.
Similarly to DNA replication, cells are obliged to dupli-
cate the translational machinery within each cell division cycle.
Thus, intact ribosome biogenesis is crucial for normal and ma-
lignant cell proliferation. For decades, nucleolar morphology
has served pathologists as a reliable indicator of malignancy.
Aberrations in the protein synthesis machinery have been fre-
quently implicated in cancer development (Ruggero and Pan-
dolfi, 2003; Holland et al., 2004). Now, intriguing connections
between cell cycle control, tumor suppressors, and nucleolar
function have emerged. Exploration of individual factors is re-
quired to unravel the complex molecular machinery of ribosome
synthesis and its role in tumor pathogenesis. Noteworthily, a re-
cent study demonstrated that Pes1 enhances colony formation
of SV40 large T-antigen immortalized cells (Maiorana et al.,
2004). Mammalian ribosome synthesis factors might be directly
implemented in malignant transformation apart from their func-
tion in ribosome synthesis. Therefore, it will be exciting to un-
ravel positive and negative regulators of ribosome synthesis and
their respective impact on tumor pathogenesis. Comparison of
ribosome biogenesis and cell growth control in noncancerous
and cancerous cells will be a promising approach to identify
novel therapeutic targets. Specific inhibition of ribosome bio-
genesis might provide a nongenotoxic chemotherapy in addi-
tion to the classic chemotherapeutic drugs.
Materials and methods
Plasmids
Human wdr12 cDNA was cloned into the EcoRV site of pUC18-HA tag us-
ing the following primers: 5 -GCCACCATGGCTCAGCTCCAAACACG-3 
and 5 -TGCCCCAACATGGGAAGTGGTAG-3 . A consensus Kozak se-
quence was added in front of the start codon. pUC18-HA tag was gen-
erated by cloning the following linker into the XbaI and HindIII sites
of pUC18: 5 -TCTAGAGGCCTCACTGGCCGGCGATATCGGTTACCC-
TTATGATGTGCCAGATTATGCCTAAGGCCAGTGAGGCCAAGCTT-3 .
pUC18-HA tag provides a COOH-terminal HA tag. Wdr12-HA was
cloned via SfiI sites into pRTS-1, a single episomal plasmid enabling tight
doxycycline-dependent gene expression. The bidirectional promoter of
pRTS-1 plasmids controls the expression of eGFP and wdr12-HA wild type
or mutants in a doxycycline-dependent manner. Human c-myc cDNA was
flanked with SfiI sites and cloned into pRTS-1. Mouse HA-bop1, HA-
bop1 , and bop1N2 cDNAs were provided by D. Pestov (University of
Illinois,  Chicago, IL) and cloned into pRTS-1 plasmids. Human wdr12
cDNA was cloned into pGEX-2T coding for a GST-WDR12 fusion protein.
HA-E6 cDNA was provided by M. Scheffner (University of Konstanz, Con-
stance, Germany) and cloned into pRTS-1 and pLXSP plasmids. Wdr12-
eYFP and eCFP-nucleophosmin expression constructs were created by
cloning wdr12 and nucleophosmin into pEYFP-N1 and pECFP-C1 plas-
mids (CLONTECH Laboratories, Inc.), respectively. Nucleophosmin cDNA
was provided by A. Lamond (University of Dundee, Dundee, UK).
Production of mAbs
Approximately 50  g of GST-WDR12 fusion protein was injected both i.p.
and subcutaneously into Lou/C rats using CPG2006 (TIB MOLBIOL) as ad-
juvant. After an 8-wk interval, a final boost was given i.p and subcutane-
ously 3 d before fusion. Fusion of the myeloma cell line P3X63-Ag8.653
with the rat immune spleen cells was performed according to standard pro-
cedures. Hybridoma supernatants were tested in a solid phase immunoas-
say. A monoclonal mouse mAb specific for the GST part of the fusion pro-
tein (M-GST 2C8, IgG1; Forschungzentrum für Umwelt und Gesundheit
Research Centre [GSF]) was coated over night at a concentration of 3  g/
ml. After blocking with nonfat milk, the GST-WDR12 fusion protein or an ir-
relevant GST fusion protein was incubated, followed by the hybridoma su-
pernatants. Bound rat mAbs were detected with a cocktail of biotinylated
mouse mAbs against the rat IgG heavy chains, thus avoiding IgM mAbs.
The biotinylated mAbs were visualized with peroxidase-labeled Avidin (Al-
exis) and o-phenylenediamine as chromogen in the peroxidase reaction.JCB • VOLUME 170 • NUMBER 3 • 2005 376
A rat mAb against GST, binding to another epitope of the GST fusion pro-
tein (GST-6G9; GSF), served as a positive control.
The hybridoma designated WDR12-1B8 was stably subcloned and
used for further analysis. The immunoglobulin isotype was determined using
mAbs against the rat IgG heavy chains and light chains. The WDR12 (1B8)
mAb has the IgG subclass IgG1. mAbs against human Pes1 (8E9) and Bop1
(6H11) were generated by using the following peptides coupled to ovalbu-
min (H.R. Rackwitz, Peptide Specialty Laboratories GmbH, Heidelberg, Ger-
many): Pes1, AGSEKEEEARLAALEEQRMEGK; Bop1, SRGAGRTAAPSVR-
PEK. The Pes1 (8E9) and Bop1 (6H11) mAbs have the IgG subclass IgG1.
Besides slight modifications, hybridoma cell lines were generated and super-
natants were tested as described in this section. Generation of the anti-cyto-
hesin antibody was described previously (Geiger et al., 2000).
Cell culture, transfections, and stable selection
TGR-1 rat fibroblasts, U2OS osteosarcoma cells, and p53 /  and
p19ARF /  MEFs were cultured in DME with 8% FBS (BioSer) at 8%
CO2. TGR-1 fibroblasts were provided by J. Sedivy (Brown University,
Providence, RI), p53 /  MEFs were provided by G. Fingerle-Rowson
(University Hospital Cologne, Cologne, Germany), and p19ARF / 
MEFs were provided by C.J. Sherr (Howard Hughes Medical Institute, St.
Jude Children’s Research Hospital, Memphis, TN). P493-6 cells were cul-
tured in RPMI with 10% FBS at 5% CO2. TGR-1 and U2OS cells,  7  
10
5, were transfected with 4  g pRTS-1 plasmids using polyfect (QIA-
GEN). Stable polyclonal cell cultures were selected in the presence of 200
 g/ml hygromycin B (TGR-1 and U2OS) or 1  g/ml puromycin (TGR-1)
for 10 to 14 d. Induction of conditional gene expression was performed
with 1  g/ml doxycycline. The percentage of eGFP-positive cells was
monitored by FACS analysis. Human diploid fibroblasts were transfected
by electroporation with 10  g of plasmid DNA.
siRNA transfection
The day before transfection,  5   10
4 to 10
5 U2OS cells were seeded in
6-well plates. 5  l of 20  M control or WDR12-specific siRNA were di-
luted in 150  l Optimem (Invitrogen). 150  l Optimem containing 5  l
Oligofectamine (Invitrogen) was added and incubated for 15 min. Finally,
600  l Optimem was added and applied to cells after aspiration of the
culture medium. Cells were incubated for 5–6 h. The following sequences
(sense) were used: WDR12, CGUACGUUUCCGUGGGCAAdTdT; Con-
trol (nonspecific siRNA), UUCUCCGAACGUGUCACGUdTdT.
Immunoblotting and immunofluorescence
TGR-1 and P493-6 cells were directly lysed in SDS-loading buffer (50 mM
Tris-HCl, 100 mM DTT, 2% SDS, 0.1% bromophenol blue, and 10% glyc-
erol). Total cell lysates were separated on SDS-PAGE gels and blotted on
nitrocellulose membranes (GE Healthcare). Equal loading was verified by
Ponceau S staining. Immunodetection was performed with anti-c-Myc
(N-262; Santa Cruz Biotechnology, Inc.), anti-WDR12 (1B8), anti-Pes1,
anti-Bop1, anti– -tubulin (DM1A; Dianova), anti-HA (3F10; Roche), anti-
p53 (Pab240; BD Biosciences), and anti–phospho-p53-Ser15 (Cell Signal-
ing Technology Inc.).
For immunofluorescence, cells were grown on coverslips and fixed
in ice-cold methanol for 10 min and air dried. Alternatively, cells were
fixed in 4% PFA for 10 min and permeabilized with PBS/Tween 0.1% for
15 min at RT. Unspecific binding was blocked with PBS/10% FBS. p53
and HA-tagged WDR12 were detected with a 1:100 dilution of anti-p53
(Pab122; Dianova) and a 1:10 dilution of 3F10 hybridoma supernatant,
respectively. Primary antibodies were incubated over night at 4 C in a hu-
midified chamber. Cy3 or FITC-labeled secondary antibodies (Dianova)
were incubated for 30 min at RT. Nuclei were counterstained with DAPI
(Sigma-Aldrich). Digital images were acquired using the Openlab acquisi-
tion software (Improvision) and a microscope (model Axiovert 200M; Carl
Zeiss MicroImaging, Inc.) with 63  (1.15) and 100  (1.30) plan oil ob-
jectives connected to a 5 charge-coupled device camera (model ORCA-
479; Hamamatsu).
BrdU light assay
BrdU lights assays were performed essentially as previously described
(Pestov and Lau, 1994). In brief, stable polyclonal TGR-1 cells were seeded
in the presence of 1  g/ml doxycycline at a density of 10
5 cells per 100-
mm well. 30 h after seeding, cells were incubated with 100  M BrdU and
doxycycline for 48 h. Culture medium was then removed and replaced by
medium containing doxycycline and Hoechst 33258 at 2  g/ml for 3 h.
Finally, cells were placed on glass 11 cm above a 30-W fluorescent day-
light bulb and irradiated from beneath for 15 min. Cells were washed in
PBS two times and regular culture medium without doxycycline was added.
RNA analysis and 
32P in vivo labeling
Total RNA of P493-6 and TGR-1 cells was isolated using Trifast (PeqLab).
10  g of total RNA was separated on a 1% agarose-formaldehyde gel
and blotted on hybond N
  membranes (GE Healthcare). The following 
32P
end-labeled DNA oligonucleotides were used to visualize rRNA precur-
sors: ITS-1 (rat specific), 5 -GGACCAGACCCGACACCCTGCCACCG-
CACACCTGTCCCGAAACCCCCT-3 ; ITS-2 (rat specific), 5 -GCCCCG-
GGGAGCGGGCCCTGCGAGCAGACTCCCAGCCGCGCGACGCGA-
3 ; ITS-1 (human specific), 5 -CCTCCGCGCCGGAACGCGCTAGGTAC-
CTGGACGGCGGGGGGGCGGACG-3 ; ITS-2 (human specific), 5 -
GCGGCGGCAAGAGGAGGGCGGACGCCGCCGGGTCTGCGCTTA-
GGGGGA-3 ; 18S rRNA (human and rat specific), 5 -CACCCGTGGT-
CACCATGGTAGGCACGGCGACTACCATCGAAAGTTGATAG-3 ; 28S
(human and rat specific), 5 -CCAGCTATCCTGAGGGAAACTTCGGAGG-
GAACCAGCTACTAGATGGTTCG-3 .
For metabolic labeling of rRNA, TGR-1 and U2OS cells were prein-
cubated in phosphate-free DME (GIBCO BRL) with dialyzed FBS (Sigma-
Aldrich) for 30 min. The medium was then replaced by phosphate-free
DME/10% dialyzed FBS containing 15  Ci/ml 
32P-orthophosphate (GE
Healthcare). After 45 min, the radioactive medium was removed and cells
were incubated in regular DME/10% FBS for 2 h. 10  g of total RNA
were separated on 1% agarose-formaldehyde gels. After electrophoresis,
gels were placed on whatman-paper and dried at 80 C under vacuum
suction. Dried agarose gels were exposed to regular x-ray films (Kodak)
and rRNA was visualized by autoradiography. A PhosphoImager (Fuji)
was used for the quantification of signal intensities.
Immunoprecipitation
3   10
7 cells were lysed in 1 ml lysis buffer (50 mM Tris-HCl, pH 8.0, 1%
NP-40, 150 mM NaCl, phosphatase inhibitors, and protease inhibitors) at
4 C for 20 min. 20  g of glass beads were washed twice with PBS and
incubated with 100  l of anti-WDR12, anti-Bop1, anti-Pes1, and anti-Cyto-
hesin supernatant for 1 h at 4 C. Afterwards, beads were washed once in
lysis buffer. Subsequently, beads were incubated with 100  l of total cell
lysate at 4 C for 5 h. Immunoprecipitations were then washed three times
with lysis buffer at 4 C and were incubated at 95 C for 10 min in a 1:1
dilution of 2  SDS loading buffer and lysis buffer. Finally, 5  l of the im-
munoprecipitations were separated by SDS-PAGE.
Quantitative real-time PCR
Asynchronously proliferating TGR-1 cells were treated with doxycycline for
30 h and total RNA was isolated using Trifast (PeqLab). cDNA was pro-
duced using 1  g of total RNA using oligo(dT)-primers and M-MLV reverse
transcriptase (Promega). Subsequently, cDNA was diluted at 1:100 for
quantitative real-time PCR using a LightCycler PCR analysis system (Roche)
according to the manufacturer’s recommendations. The following primers
were used for detection of rat p21 mRNA: 5 -TGTTCCACACAGGAG-
CAAAG-3  and 5 -CTCTTGCAGAAGACCAATCG-3 . Quantitative real-
time PCR of aldolase was performed for normalization using the following
primers: 5 -GGTCACAGCACTTCGTCGCACAG-3  and 5 -TCCTTGA-
CAAGCGAGGCTGTTGGC-3 .
Native gel and two-dimensional gel electrophoresis
3   10
6 cells were lysed in 100  l lysis buffer at 4 C for 20 min. 7.5  l
of 2  sample buffer (125 mM Tris-HCl, pH 6.8, 30% glycerol, and
0.02% bromphenol blue) was added to 7.5  l of total cell lysate and sep-
arated by PAGE (6.5%) in the absence of SDS at 4 C. The voltage did not
exceed 100 V during electrophoresis. Blotting was performed in the ab-
sence of methanol. Immunoblotting was performed as described in the Im-
munoblotting and immunofluorescence section. For two-dimensional gel
electrophoresis, subsequently to native gel electrophoresis, the appropri-
ate lanes were cut out from the gel and incubated in SDS-running buffer
for 10 min. Afterwards, the strips were applied horizontally to second di-
mension SDS-PAGE (10%). Immunoblotting was performed as described
in the Immunoblotting and immunofluorescence section.
Online supplemental material
Fig. S1 shows cell cycle analysis of WDR12 mutant–expressing cells. Fig.
S2 shows analysis of p53 phosphorylation at serine 15 in response to
dominant-negative WDR12. Online supplemental material is available at
http://www.jcb.org/cgi/content/full/jcb.200501141/DC1.
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